Rozga J, Podesta L, LePage E, Hoffman A, Morsiani E, Sher L, Woolf G M, Makowka L, Demetriou A A
Liver Support Unit, Cedars-Sinai Medical Center, Los Angeles, California 90048-1865.
Lancet. 1993 Oct 9;342(8876):898-9. doi: 10.1016/0140-6736(93)91947-k.
Keeping a patient with fulminant hepatic failure (FHF) alive until a donor liver is available for transplantation can be a problem. We describe an 18-year-old woman with paracetamol-induced FHF, who was treated by total hepatectomy, hypothermia, plasma exchange, and extracorporeal liver support. The patient was anhepatic for 14 h. The liver-support system consisted of plasma separation and perfusion through a charcoal filter and a hollow-fibre module seeded with matrix-attached porcine hepatocytes. With artificial liver treatment there was reversal of severe neurological dysfunction, normalisation of intracranial pressure, and decreased serum ammonia. The patient underwent emergency transplantation with an ABO-incompatible liver, followed by transplantation with a compatible organ eight days later. The patient has fully recovered and is neurologically intact.
在有供体肝脏可用于移植之前维持暴发性肝衰竭(FHF)患者的生命可能是个难题。我们描述了一名18岁因对乙酰氨基酚导致FHF的女性患者,她接受了全肝切除术、低温治疗、血浆置换和体外肝脏支持治疗。该患者无肝期长达14小时。肝脏支持系统包括血浆分离以及通过装有活性炭过滤器和接种有附着于基质的猪肝细胞的中空纤维模块进行灌注。通过人工肝治疗,严重的神经功能障碍得到逆转,颅内压恢复正常,血清氨水平降低。该患者先接受了ABO血型不相合肝脏的紧急移植,八天后又接受了相容性器官的移植。患者已完全康复,神经功能完好。